AURA Stock Price History and Quote Analysis: Insights for Investors
Aura Biosciences, Inc.
Stock Price Today
Aura Biosciences, Inc. (AURA) stock surged +7.94%, trading at $9.79 on NASDAQ, up from the previous close of $9.07. The stock opened at $10.03, fluctuating between $9.44 and $10.75 in the recent session.
Stock Snapshot
Stock Price History Chart
Contact Details
About Company
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develops AU-011 in additional ocular oncology indications, including choroidal metastases. The company was incorporated in 2009 and is headquartered in Cambridge, Massachusetts.
Company Information
| Employees | 88 |
| Beta | 0.35 |
| Sales or Revenue | $0.00 |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Biotechnology |
Frequently Asked Questions
Aura Biosciences, Inc. (NASDAQ: AURA) stock price is $9.79 in the last trading session. During the trading session, AURA stock reached the peak price of $10.75 while $9.44 was the lowest point it dropped to. The percentage change in AURA stock occurred in the recent session was 7.94% while the dollar amount for the price change in AURA stock was $0.72.
The NASDAQ listed AURA is part of Biotechnology industry that operates in the broader Healthcare sector. Aura Biosciences, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.
Dr. Cadmus Collins Rich CPE, M.B.A., M.D., MBA
Chief Medical Officer and Head of R&D
Ms. Michele Keough M.B.A.
Senior Vice President of Project Management and Device Supply Chain
Dr. Elisabet de los Pinos Ph.D.
Founder, Chief Executive Officer, Pres & Director
Ms. Julie B. Feder
Chief Financial Officer, Sec. & Treasurer
Mr. Patrick Nealon
Senior Vice President of Clinical Devel. Operations
Dr. Mark A. De Rosch Ph.D.
Chief Operating Officer
Mr. Paulo Carvalho
Vice President of Technical Operations
AURA's closing price is 63.44% higher than its 52-week low of $5.99 where as its distance from 52-week high of $12.35 is -20.73%.
Number of AURA employees currently stands at 88.
Official Website of AURA is: https://www.aurabiosciences.com
AURA could be contacted at phone 617 500 8864 and can also be accessed through its website. AURA operates from 85 Bolton Street, Cambridge, MA 02140, United States.
AURA stock volume for the day was 441K shares. The average number of AURA shares traded daily for last 3 months was 177.2K.
The market value of AURA currently stands at $485.64M with its latest stock price at $9.79 and 49.61M of its shares outstanding.
Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.
© 2024 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com